研究

Research achievements

研究業績・受賞

原著(2019年)
1.

Kamon D, Okura H, Okamura A, Nakada Y, Hashimoto Y, Sugawara Y, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.
Circ J. 2019 Apr 20.

2.

Kanaoka K, Okayama S, Nakai M, Sumita Y, Nishimura K, Kawakami R, Okura H, Miyamoto Y, Yasuda S, Tsutsui H, Komuro I, Ogawa H, Saito Y.
Hospitalization Costs for Patients With Acute Congestive Heart Failure in Japan.
Circ J. 2019 Apr 25;83(5):1025-1031.

3.

Kanaoka K, Okayama S, Nakai M, Sumita Y, Onoue K, Soeda T, Nishimura K, Kawakami R, Okura H, Miyamoto Y, Yasuda S, Tsutsui H, Komuro I, Ogawa H, Saito Y.
Number of Cardiologists per Cardiovascular Beds and In-Hospital Mortality for Acute Heart Failure: A Nationwide Study in Japan.
J Am Heart Assoc. 2019 Sep 17;8(18):

4.

Nakada Y, Kawakami R, Matsui M, Ueda T, Nakano T, Nakagawa H, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Saito Y.
Value of Placental Growth Factor as a Predictor of Adverse Events During the Acute Phase of Acute Decompensated Heart Failure.
Circ J. 2019 Jan 25;83(2):395-400.

5.

Nakada Y, Kawakami R, Matsushima S, Ide T, Kanaoka K, Ueda T, Ishihara S, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Tsuchihashi-Makaya M, Tsutsui H, Saito Y.
Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure - A 2 B Score.
Circ J. 2019 Mar 7.

6.

Nakada Y, Onoue K, Nakano T, Ishihara S, Kumazawa T, Nakagawa H, Ueda T, Nishida T, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels.
Sci Rep. 2019 Oct 30;9(1):15571.

7.

Nogi Kazutaka, Shiraishi Atsushi, Yamamoto Ryohei, Sasano Mikio, Matsumoto Takashi, Karumai Toshiyuki, Hayashi Yoshiro.
Intermittent Hemodialysis for Managing Metabolic Acidosis During Resuscitation of Septic Shock: A Descriptive Study.
Critical Care Explorations: December 2019 – Volume 1 – Issue 12.

8.

Okura H, Nakada Y, Ishihara S, Nogi M, Onoue K, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
“Hidden” takotsubo cardiomyopathy in cardiac care unit.
J Echocardiogr. 2019 Dec 13.

9.

Onoue K, Takemura G, Nakano T, Miyazaki N, Tsujimoto A, Watanabe T, Okada H, Kanamori H, Sugiura J, Kanaoka K, Ishihara S, Horii M, Akai Y, Sakaguchi Y, Saito Y.
Ultrastructural Evidence of Glycosphingolipid Degradation After Enzyme Replacement Therapy in Patients With Fabry Disease.
Circ J. 2019 Mar 29.

10.

Soejima H, Ogawa H, Morimoto T, Okada S, Sakuma M, Nakayama M, Masuda I, Doi N, Uemura S, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators.
One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
J Cardiol. 2019 Jan;73(1):33-37.

11.

Takemura G, Onoue K, Nakano T, Nakamura T, Sakaguchi Y, Tsujimoto A, Miyazaki N, Watanabe T, Kanamori H, Okada H, Kawasaki M, Fujiwara T, Fujiwara H, Saito Y.
Possible mechanism for disposal of degenerative cardiomyocytes in human failing hearts: phagocytosis by a neighbour.
ESC Heart Fail. 2019 Feb;6(1):208-216.

12.

Ueda T, Kawakami R, Nakada Y, Nakano T, Nakagawa H, Matsui M, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Saito Y.
Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
ESC Heart Fail. 2019 Jul 19.

受賞(2020年)
1.

第28回(2020年度)バイエル循環器病研究助成
金岡 幸嗣朗
「医療・介護レセプトデータを用いた、脳・心・腎疾患終末期の実態把握と、それを利用した、終末期医療の質向上に対する提言」

2.

第13回国際心臓研究学会(ISHR) world congress, President’s Distinguished Lecture
斎藤 能彦
「Molecular mechanism for cardio‐renal connection」

3.

第33回日本心血管インターベンション治療学会(CVIT)
奥 翔平
「TAVI予定であったが、牛肉および豚肉アレルギーを有するため、BAVに治療方針を変更した高齢者大動脈弁狭窄症の1例」

ACCESS

ご来院の方へ ─アクセス─

アクセスマップ・公共交通機関のご案内・駐車場のご案内など、詳しくは以下からご確認ください。